Pembrolizumab in combination with radiotherapy for metastatic melanoma - introducing the PERM trial.
Authors
Yip, KMelcher, A
Harrington, K
Illidge, Timothy M
Nobes, J
Webster, A
Smith, D
Lorigan, Paul C
Nathan, P
Larkin, J
Affiliation
Ipswich Hospital, Ipswich, UKIssue Date
2018-04
Metadata
Show full item recordCitation
Pembrolizumab in combination with radiotherapy for metastatic melanoma - introducing the PERM trial. 2018, 30(4):201-203 Clin OncolJournal
Clinical OncologyDOI
10.1016/j.clon.2018.01.001PubMed ID
29402599Type
ArticleLanguage
enDescription
Lymphoma Research TeamISSN
1433-2981ae974a485f413a2113503eed53cd6c53
10.1016/j.clon.2018.01.001